Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis

por Saida, Takahiko, Hao, Qi, Kanda, Michihiro, Tani, Yumiko
Publicado 2023

Natalizumab for Achieving Relapse-Free, T1 Gadolinium-Enhancing-Lesion-Free, and T2 Lesion-Free Status in Japanese Multiple Sclerosis Patients: A Phase 2 Trial Subanalysis

por Saida, Takahiko, Kira, Jun-Ichi, Kishida, Shuji, Yamamura, Takashi, Ohtsuka, Nobuhisa, Dong, Qunming, Tibung, J. T.
Publicado 2017

Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan

por Saida, Takahiko, Yokoyama, Kazumasa, Sato, Ryusuke, Makioka, Haruki, Iizuka, Yukihiko, Hase, Masakazu, Ling, Yan, Torii, Shinichi
Publicado 2017

HSV-2–related hemophagocytic lymphohistiocytosis in a fingolimod-treated patient with MS

por Ikumi, Kazuhiro, Ando, Tetsuo, Katano, Harutaka, Katsuno, Masahisa, Sakai, Yu, Yoshida, Mari, Saida, Takahiko, Kimura, Hiroshi, Sobue, Gen
Publicado 2016

A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries

por Saida, Takahiko, Yamamura, Takashi, Kondo, Takayuki, Yun, Jang, Yang, Minhua, Li, Jie, Mahadavan, Lalitha, Zhu, Bing, Sheikh, Sarah I.
Publicado 2019

Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study

por Saida, Takahiko, Itoyama, Yasuto, Kikuchi, Seiji, Hao, Qi, Kurosawa, Takayoshi, Ueda, Kengo, Auberson, Lixin Zhang, Tsumiyama, Isao, Nagato, Kazuo, Kira, Jun-ichi
Publicado 2017

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

por Kira, Jun-ichi, Itoyama, Yasuto, Kikuchi, Seiji, Hao, Qi, Kurosawa, Takayoshi, Nagato, Kazuo, Tsumiyama, Isao, von Rosenstiel, Philipp, Zhang-Auberson, Lixin, Saida, Takahiko
Publicado 2014

Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial

por Saida, Takahiko, Kira, Jun-Ichi, Kishida, Shuji, Yamamura, Takashi, Ohtsuka, Nobuhisa, Ling, Yan, Torii, Shinichi, Lucas, Nisha, Kuesters, Geoffrey, Steiner, Deb, Tibung, J. T.
Publicado 2016

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

por Nakamura, Yuri, Gaetano, Laura, Matsushita, Takuya, Anna, Altermatt, Sprenger, Till, Radue, Ernst-Wilhelm, Wuerfel, Jens, Bauer, Lorena, Amann, Michael, Shinoda, Koji, Isobe, Noriko, Yamasaki, Ryo, Saida, Takahiko, Kappos, Ludwig, Kira, Jun-ichi
Publicado 2018